Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers July 23, 2017

Poll Results
How likely would you be to recommend the addition of an SGLT-2 drug in a patient with diabetes because of this study showing modest cardiovascular mortality reduction?
  Very likely 31.0%
  Likely 29.4%
  Not likely 32.5%
  Very unlikely 7.1%

  Total # Taken: 126

Previous Polls
How likely would you be to recommend Qtern® in a patient already receiving dapagliflozin and saxagliptin with good blood glucose control?
How likely would you be to recommend Basaglar® as an alternative to Lantus®?
How likely would you be to recommend safinamide for a patient with Parkinson’s disease on levodopa/carbidopa with significant “off” periods?
Do you agree that a target blood pressure of 140/90 or less is appropriate for most low-risk patients less than 60 years of age?
How often have you encountered the new heart failure drug, ivabradine (Corlanor), as either non-formulary, or prior authorization only status?
How often have you counseled about potential long-term side effects and/or Black Box warnings with topical tacrolimus or pimecrolimus?
How often have you contacted a prescriber upon suspecting testosterone abuse in a patient?
How likely would you be to request that a physician change a prescription from EpiPen® to Adrenaclick® for a patient without insurance coverage?
How likely would you be to support regulation aimed at restricting or limiting the sale of OTC loperamide?
How likely are you to recommend a quinolone antibiotic for an adult patient with an upper respiratory tract infection?


Websites » RxCareerCenter.comRxSchool.comClubStaffing.comNursingJobSource.comRN.com
Copyright © 2017 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415